Trial: 202011088

AN OPEN-LABEL, PHASE III STUDY OF PLATINUM-GEMCITABINE WITH OR WITHOUT NIVOLUMAB IN THE FIRST-LINE TREATMENT OF RECURRENT OR METASTATIC NASOPHARYNGEAL CARCINOMA

Phase

III

Principal Investigator

Oppelt, Peter

Disease Site

Lip, Oral Cavity and Pharynx

Learn more about this study at: clinicaltrials.gov